Literature DB >> 11917222

Glassy cell carcinoma of the uterine cervix: histochemical, immunohistochemical, and molecular genetic observations.

Noriko Kato1, Yousei Katayama, Mitsuomi Kaimori, Teiichi Motoyama.   

Abstract

Glassy cell carcinoma (GCC) of the uterine cervix is characterized by distinctive cytological features and an aggressive clinical course. Although this tumor has been usually considered a poorly differentiated variety of adenosquamous carcinoma (ASC), a clarification of the phenotype and histogenesis of GCC is still required. We examined three GCCs and four ASCs for histochemical and immunohistochemical phenotypes and molecular genetic status, comparing them with five nonkeratinizing squamous cell carcinomas and five endocervical-type mucinous adenocarcinomas. GCCs had a profile of cytokeratin expression similar to that of reserve cells or immature squamous cells of the cervix. In addition to squamous differentiation, GCCs sporadically produced intestinal-type mucin. HPV 18 was detected in two of three GCCs and two of four ASCs. GCCs may originate from multipotential stem or reserve cells that undergo early squamous differentiation. The presence of HPV 18 might stimulate biphasic squamous and glandular differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11917222     DOI: 10.1097/00004347-200204000-00005

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  3 in total

1.  Cytomorphological characteristics of glassy cell carcinoma of the uterine cervix: histopathological correlation and human papillomavirus genotyping.

Authors:  Yoon Yang Jung; Ji Hae Nahm; Hyun-Soo Kim
Journal:  Oncotarget       Date:  2016-11-08

2.  Clinical outcomes of advanced-stage glassy cell carcinoma of the uterine cervix: a need for reappraisal.

Authors:  Nara Yoon; Ji-Ye Kim; Hyun-Soo Kim
Journal:  Oncotarget       Date:  2016-11-29

3.  Glassy cell carcinoma of cervix: an analysis for 20 cases and literatures review.

Authors:  Qingxuan Wang; Yuanjing Hu; Ya He; Tian Wang; Pratima Ghimire
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.